This is an exclusive BHB+ story Substance use disorder (SUD) treatment providers could be entering a period of significant disruption. The industry, which has been relatively stagnant in the field of new treatment modalities, may see the rise of new medications and technologies. But that’s not the only disruption to the sector I foresee. Now […]
The experience of the addiction treatment industry in the five years since the onset of the COVID-19 pandemic illustrates the resilience of the industry. The industry is best defined by its ability to adapt to a constantly changing environment. COVID changed so much in American society and the economy nearly overnight; the addiction industry, in particular, […]
Guidelight Health promotes chief operating officer to lead as CEO Guidelight has tapped Stephen Bewley as its new CEO. Bewley initially joined Guidelight Health in February as chief operating officer. He will replace Andrew Hayek, who served as the company’s interim CEO. Before joining Guidelight, Bewley served as the chief operating officer at InStride Health, […]
Fewer than one in five Medicare patients with a substance use disorder (SUD) receive medication-assisted-treatment (MAT), including popular options such as buprenorphine and methadone, to treat their condition. Still, the number of providers prescribing buprenorphine for Medicare beneficiaries rose by 32% in 2023. This is according to a new report from the U.S. Department of […]
Behavioral health providers have faced regulatory uncertainty regarding government funding and access to Medicaid this week. The Trump administration issued a funding freeze on Monday only for it to be blocked by a federal judge on Tuesday. States reported outages to the Medicaid portal on Tuesday and more interruptions on Wednesday, while the White House […]
The landscape of substance use disorder (SUD) treatment in 2024 was a tapestry of challenges, technological disruptions and unexpected breakthroughs. A staggering data leak exposed the personal information of 100 million patients. Economic pressures forced some SUD providers to retreat from certain state markets, and long-anticipated regulatory changes were once again delayed, leaving the industry […]
Last year, Ozempic took the weight loss industry by storm; could the substance use disorder industry be next? It’s possible, according to some industry insiders. But that’s not the only trend likely to shape 2025. New drugs, technologies, payer trends and care models set the stage for 2025 to be a transformative year for the […]
Certain sectors of behavioral health care are still “growing up.” For example, some industry insiders have said the autism therapy industry is in its toddler phase. The SUD industry, meanwhile, is working to shed some of the associations of its youth and enter a more adult era of addiction treatment. Some providers are modernizing their […]
Substance use disorder (SUD) providers are looking for new ways to expand their business offerings and partners to boost revenue. Diversifying offerings is one of the most popular ways to improve revenue generation. For many providers, this means increasing their continuum of care to include acute residential services through intensive outpatient programs [IOPs] and outpatient […]
State Medicaid programs and their managed care organization (MCO) partners are amenable to value-based care contracting. However, misconceptions remain as the industry navigates the early stages of value-based care adoption. This openness allows companies to come to the table with new or different approaches to contracting, opening the door to escaping the fee-for-service paradigm. “The […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
